Gufic Biosciences Announces 42nd AGM on Sep 4, 2026, via VC/OAVM
Gufic Biosciences Limited will hold its 42nd AGM on September 4, 2026, via video conference. The company has dispatched the AGM notice and annual report electronically. Remote e-voting will be available from September 1 to September 3, 2026. The Register of Members will close from August 29 to September 4, 2026.
The announcement pertains to a standard procedural event (AGM) and does not involve any significant new business developments, financial results, or strategic changes that would materially impact the company's operations or stock.
The announcement is a routine corporate event (AGM notice) and does not contain any new financial or business information that would sway sentiment.
Gufic Biosciences Limited has announced its 42nd Annual General Meeting (AGM) will be held on Friday, September 04, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has completed the electronic dissemination of the AGM notice and the Annual Report for FY 2025-26 to members on Wednesday, August 12, 2026. A physical dispatch of a letter providing the web-link for the Annual Report was also made on the same day to members who have not registered their email IDs. Shareholders will have the facility for remote e-voting from Tuesday, September 01, 2026, 9:00 a.m. IST, to Thursday, September 03, 2026, 5:00 p.m. IST. The Register of Members and Share Transfer Books will remain closed from Saturday, August 29, 2026, to Friday, September 04, 2026, inclusive, for the purpose of the AGM and payment of final dividend for the financial year ended March 31, 2026, if approved.
What to do with a filing like this
Gufic Biosciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.